The Liposarcoma Treatment Market was valued at USD 1.5 billion in 2024 and is projected to reach USD 3.2 billion by 2034, registering a CAGR of 8.1%. This growth trajectory is underpinned by several critical factors, including an increasing incidence of liposarcoma, advancements in treatment modalities, and a growing emphasis on personalized medicine. The rising awareness of rare cancers and...